Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Colonic Diseases × trimebutine 3-thiocarbamoylbenzenesulfonate × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Visceral Pain 1 Pain 1 Neoplasms 1 Colonic Neoplasms 1 Colonic Diseases 1 Agnosia 1

Interventions

trimebutine 3-thiocarbamoylbenzenesulfonate 1 guadecitabine 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02276768 2016-08-10

Study on Analgesia of GIC-1001 & GIC-1002 on Visceral Pain, Rectal Sensory Threshold Using the Barostat Method

gicare Pharma Inc.

Phase 1 Completed

Gastrointestinal

Agnosia, Colonic Diseases, Colonic Neoplasms, Neoplasms, Pain, Visceral Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡